Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             26 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension Lee, Jang Hoon
2016
38 6 p. 1485-1497
13 p.
artikel
2 A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Collatz, Ansel
2016
38 6 p. 1263-1271.e9
1.270999998738E12 p.
artikel
3 Bioavailability of Methadone After Sleeve Gastrectomy: A Planned Case Observation Strømmen, Magnus
2016
38 6 p. 1532-1536
5 p.
artikel
4 Clinical Implications of Cardiovascular Outcome Trials in Type 2 Diabetes: From DCCT to EMPA-REG Rydén, Lars
2016
38 6 p. 1279-1287
9 p.
artikel
5 Clinical Utility of Basophil CD203c as a Biomarker for Predicting the Timing of Hypersensitivity Reaction in Carboplatin Rechallenge: Three Case Reports Iwamoto, Takuya
2016
38 6 p. 1537-1541
5 p.
artikel
6 Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial Pinckney, Ashley
2016
38 6 p. 1327-1339
13 p.
artikel
7 Early Pharmacodynamic Effects of Exenatide Once Weekly in Type 2 Diabetes Are Independent of Weight Loss: A Pooled Analysis of Patient-level Data Trautmann, Michael E.
2016
38 6 p. 1464-1473
10 p.
artikel
8 Economic Analysis of Panitumumab Compared With Cetuximab in Patients With Wild-type KRAS Metastatic Colorectal Cancer That Progressed After Standard Chemotherapy Graham, Christopher N.
2016
38 6 p. 1376-1391
16 p.
artikel
9 Editorial Board 2016
38 6 p. A2-
1 p.
artikel
10 Efficacy and Safety Profile of Anti–tumor Necrosis Factor-α Versus Anti-integrin Agents for the Treatment of Crohn’s Disease: A Network Meta-analysis of Indirect Comparisons Miligkos, Michael
2016
38 6 p. 1342-1358.e6
1.357998659E9 p.
artikel
11 Efficacy, Safety, and Tolerability of Fulranumab as an Adjunctive Therapy in Patients With Inadequately Controlled, Moderate-to-Severe Chronic Low Back Pain: A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Dose-loading Phase II Study Sanga, Panna
2016
38 6 p. 1435-1450
16 p.
artikel
12 EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus Schernthaner, Guntram
2016
38 6 p. 1288-1298
11 p.
artikel
13 Engaging Participants in Rare Disease Research: A Qualitative Study of Duchenne Muscular Dystrophy Bendixen, Roxanna M.
2016
38 6 p. 1474-1484.e2
146927 p.
artikel
14 Evidence for Good Cardiovascular Outcomes among Patients with Type 2 Diabetes, and Promising Treatment for Patients with Type 1 Diabetes Ryan, John G.
2016
38 6 p. 1274-1278
5 p.
artikel
15 Initial Experience With Tofacitinib in Clinical Practice: Treatment Patterns and Costs of Tofacitinib Administered as Monotherapy or in Combination With Conventional Synthetic DMARDs in 2 US Health Care Claims Databases Harnett, James
2016
38 6 p. 1451-1463
13 p.
artikel
16 Longitudinal Changes in Medical Services and Related Costs in a Single Cohort of Patients Newly Diagnosed With Type 2 Diabetes, 2006 to 2012 Weng, Wayne
2016
38 6 p. 1314-1326
13 p.
artikel
17 Lorcaserin in Obese and Overweight Patients Taking Prohibited Serotonergic Agents: A Retrospective Analysis Nguyen, Charles T.
2016
38 6 p. 1498-1509
12 p.
artikel
18 Pathogen Prevalence and Antimicrobial Susceptibility Among Enterobacteriaceae Causing Hospital-associated Intra-abdominal Infections in Adults in the United States (2012–2013) Zalacain, Magdalena
2016
38 6 p. 1510-1521
12 p.
artikel
19 Rescue Sedation With Intranasal Dexmedetomidine for Pediatric Ophthalmic Examination After Chloral Hydrate Failure: A Randomized, Controlled Trial Gan, Xiaoliang
2016
38 6 p. 1522-1529
8 p.
artikel
20 Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes Kohler, Sven
2016
38 6 p. 1299-1313
15 p.
artikel
21 Safety of Concomitant Metformin and Proton Pump Inhibitor Use: A Population Retrospective Cohort Study Chen, Christopher B.
2016
38 6 p. 1392-1400
9 p.
artikel
22 Safety, Pharmacokinetic, and Pharmacodynamic Evaluation After Single and Multiple Ascending Doses of a Novel Selective Androgen Receptor Modulator in Healthy Subjects Bhattacharya, Indranil
2016
38 6 p. 1401-1416
16 p.
artikel
23 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus Cohen, Stanley
2016
38 6 p. 1417-1434.e2
141984 p.
artikel
24 Some Reflections on Diabetes Mellitus Shader, Richard I.
2016
38 6 p. 1259-1261
3 p.
artikel
25 Table of Contents 2016
38 6 p. A4-A6
nvt p.
artikel
26 Treatment Patterns, Direct Cost of Biologics, and Direct Medical Costs for Rheumatoid Arthritis Patients: A Real-world Analysis of Nationwide Japanese Claims Data Sugiyama, Naonobu
2016
38 6 p. 1359-1375.e1
12392 p.
artikel
                             26 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland